Position in IONS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$5,133,828
+$4,777,289 QoQ
Shares Held
68,369
+1154.5% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Edgestream Partners, L.P. holds $88,282,973 across 25 Biotechnology names. IONS ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
157,472 | $14,821,264 | |
| 2 | EXEL |
Exelixis, Inc.
|
174,455 | $7,482,374 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
69,262 | $6,735,729 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
91,997 | $5,768,211 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
168,351 | $5,592,620 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
This page
|
68,369 | $5,133,828 | |
| 7 | AGIO |
Agios Pharmaceuticals, Inc.
|
143,731 | $4,862,419 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
191,328 | $4,258,961 |
All Filings in IONS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,133,828 | 68,369 | Shares | Sole | 2026-05-18 | |
| 2025-09-30 | $356,539 | 5,450 | Shares | Sole | 2025-11-12 | |
| 2024-03-31 | $764,954 | 17,646 | Shares | Sole | 2024-05-10 | |
| 2022-12-31 | $1,034,633 | 27,393 | Shares | Sole | 2023-02-13 | |
| 2021-06-30 | $1,247,041 | 31,262 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||